Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • February 6, 2014
  • /
  • FDA IP Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements
  • /
  • Life Science Matters
        Litigation
  • Abbott Hit with 5 AndroGel Suits in FDA Probe’s Wake (subscription required)
  • Pradaxa Litigation Fines Upheld, Non-Monetary Sanctions Overturned
  • J&J Punished for Losing Evidence in Vaginal Mesh MDL (subscription required)
  • Negligent Drug Design Claims May Increase in Pa. (subscription required)
  • 9th Circ. Urged to Reinstate Expert in Novartis Jaw Injury Suit (subscription required)
  • Deferred Sanctions Leave Hope for Takeda in Actos MDL (subscription required)
  • 1st Circ. Holds FCA Relator’s Feet to Rule 9(b) Fire (subscription required)
  • Biomet To
…
Continue reading...
  • Abbott Actos MDL AndroGel AndroGel lawsuit biomet biosimilars boehringer byetta children's tylenol FCA relator hip replacement settlement investigational new drug application januvia januvia lawsuit negligent drug design claims novartis jaw lawsuit pradaxa pradaxa litigation pradaxa sanctions Stem cell treatments stryker Stryker hip lawsuit takeda vaginal mesh YoungYou
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2023 · Goldberg Segalla